{
  "id": "Risk_Score_Asthma_Exacerbation.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2020-08-25",
      "name": "Therese Lindberg",
      "organisation": "Cambio CDS",
      "email": "therese.lindberg@cambio.se"
    },
    "lifecycle_state": "Initial",
    "details": {
      "en": {
        "id": "en",
        "purpose": "To predict likelihood of asthma exacerbation within 6 months.",
        "keywords": [
          "risk",
          "score",
          "RSE",
          "BMI",
          "postbronchodilator FEV1",
          "rescue inhaler",
          "asthma exacerbation"
        ],
        "use": "RSE score is caluclated based on 5 parameters: BMI, Asthma control questionaire score, postbronchodialator FEV1, rescue inhaler usage and global initiative for asthma treatment step 4 or higher. \n\nScore interpretation:\nRSE Score         Likelihood of exacerbation in 6 months\n0-10                   5%\n11-20                 5-7%\n21-30                 7-10%\n31-40                10-12%\n41-50                12-15%\n51-60                15-18%\n61-70                18-24%\n71-80                24-30%\n81-90                30-37%\n91-100              37-45%",
        "copyright": "@CambioCDS"
      }
    },
    "other_details": {
      "references": "1. Bateman ED. et al. Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations. Journal of Allergy and Clinical Immunology, Volume 135, Issue 6, 1457-1464.e4"
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-OBSERVATION.body_mass_index.v2",
        "template_id": "openEHR-EHR-OBSERVATION.body_mass_index.v2",
        "type": "INPUT",
        "elements": {
          "gt0003": {
            "id": "gt0003",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0004]"
          }
        }
      },
      "gt0004": {
        "id": "gt0004",
        "model_id": "openEHR-EHR-EVALUATION.risk_score_asthma_exacerbation.v0",
        "template_id": "openEHR-EHR-EVALUATION.risk_score_asthma_exacerbation.v0",
        "type": "INPUT",
        "elements": {
          "gt0005": {
            "id": "gt0005",
            "path": "/data[at0001]/items[at0005]"
          },
          "gt0006": {
            "id": "gt0006",
            "path": "/data[at0001]/items[at0009]"
          },
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/items[at0013]"
          },
          "gt0008": {
            "id": "gt0008",
            "path": "/data[at0001]/items[at0017]"
          }
        }
      },
      "gt0009": {
        "id": "gt0009",
        "model_id": "openEHR-EHR-EVALUATION.risk_score_asthma_exacerbation.v0",
        "template_id": "openEHR-EHR-EVALUATION.risk_score_asthma_exacerbation.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0010": {
            "id": "gt0010",
            "path": "/data[at0001]/items[at0002]"
          },
          "gt0011": {
            "id": "gt0011",
            "path": "/data[at0001]/items[at0020]"
          },
          "gt0012": {
            "id": "gt0012",
            "path": "/data[at0001]/items[at0021]"
          }
        }
      }
    },
    "default_actions": [
      "$gt0010|BMI ≥30 kg/m²|=0|local::at0003|No +0|"
    ],
    "rules": {
      "gt0013": {
        "id": "gt0013",
        "priority": 12,
        "when": [
          "$gt0003|Body Mass Index|>=30,kg/m2"
        ],
        "then": [
          "$gt0010|BMI ≥30 kg/m²|=14|local::at0004|Yes +14|"
        ]
      },
      "gt0014": {
        "id": "gt0014",
        "priority": 11,
        "when": [
          "$gt0003|Body Mass Index|!=null",
          "$gt0005|Asthma Control Questionnaire-5 (ACQ-5) Score|!=null",
          "$gt0006|Postbronchodilator FEV1 (% Predicted normal value)|!=null",
          "$gt0007|Rescue inhaler usage per day|!=null",
          "$gt0008|Global Initiative for Asthma (GINA) treatment step 4 or higher. Medium-high inhaled steroid/long acting beta agonist.|!=null"
        ],
        "then": [
          "$gt0011|RSE Score|.magnitude=$gt0005.value+$gt0006.value+$gt0007.value+$gt0008.value+$gt0010.value"
        ]
      },
      "gt0015": {
        "id": "gt0015",
        "priority": 10,
        "when": [
          "$gt0011|RSE Score|>=0",
          "$gt0011|RSE Score|<=10"
        ],
        "then": [
          "$gt0012|Likelihood of exacerbation in 6 months|='5%'"
        ]
      },
      "gt0016": {
        "id": "gt0016",
        "priority": 9,
        "when": [
          "$gt0011|RSE Score|>10",
          "$gt0011|RSE Score|<=20"
        ],
        "then": [
          "$gt0012|Likelihood of exacerbation in 6 months|='5-7%'"
        ]
      },
      "gt0017": {
        "id": "gt0017",
        "priority": 8,
        "when": [
          "$gt0011|RSE Score|>20",
          "$gt0011|RSE Score|<=30"
        ],
        "then": [
          "$gt0012|Likelihood of exacerbation in 6 months|='7-10%'"
        ]
      },
      "gt0018": {
        "id": "gt0018",
        "priority": 7,
        "when": [
          "$gt0011|RSE Score|>30",
          "$gt0011|RSE Score|<=40"
        ],
        "then": [
          "$gt0012|Likelihood of exacerbation in 6 months|='10-12%'"
        ]
      },
      "gt0019": {
        "id": "gt0019",
        "priority": 6,
        "when": [
          "$gt0011|RSE Score|>40",
          "$gt0011|RSE Score|<=50"
        ],
        "then": [
          "$gt0012|Likelihood of exacerbation in 6 months|='12-15%'"
        ]
      },
      "gt0020": {
        "id": "gt0020",
        "priority": 5,
        "when": [
          "$gt0011|RSE Score|>50",
          "$gt0011|RSE Score|<=60"
        ],
        "then": [
          "$gt0012|Likelihood of exacerbation in 6 months|='15-18%'"
        ]
      },
      "gt0021": {
        "id": "gt0021",
        "priority": 4,
        "when": [
          "$gt0011|RSE Score|>60",
          "$gt0011|RSE Score|<=70"
        ],
        "then": [
          "$gt0012|Likelihood of exacerbation in 6 months|='18-24%'"
        ]
      },
      "gt0022": {
        "id": "gt0022",
        "priority": 3,
        "when": [
          "$gt0011|RSE Score|>70",
          "$gt0011|RSE Score|<=80"
        ],
        "then": [
          "$gt0012|Likelihood of exacerbation in 6 months|='24-30%'"
        ]
      },
      "gt0023": {
        "id": "gt0023",
        "priority": 2,
        "when": [
          "$gt0011|RSE Score|>80",
          "$gt0011|RSE Score|<=90"
        ],
        "then": [
          "$gt0012|Likelihood of exacerbation in 6 months|='30-37%'"
        ]
      },
      "gt0024": {
        "id": "gt0024",
        "priority": 1,
        "when": [
          "$gt0011|RSE Score|>90",
          "$gt0011|RSE Score|<=100"
        ],
        "then": [
          "$gt0012|Likelihood of exacerbation in 6 months|='37-45%'"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "Risk Score for Asthma Exacerbation (RSE)",
            "description": "Risk Score for Asthma Exacerbation (RSE) predicts likelihood of asthma exacerbation within 6 months."
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Body Mass Index",
            "description": "Index describing ratio of weight to height."
          },
          "gt0005": {
            "id": "gt0005",
            "text": "Asthma Control Questionnaire-5 (ACQ-5) Score",
            "description": "*"
          },
          "gt0006": {
            "id": "gt0006",
            "text": "Postbronchodilator FEV1 (% Predicted normal value)",
            "description": "*"
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Rescue inhaler usage per day",
            "description": "*"
          },
          "gt0008": {
            "id": "gt0008",
            "text": "Global Initiative for Asthma (GINA) treatment step 4 or higher. Medium-high inhaled steroid/long acting beta agonist.",
            "description": "*"
          },
          "gt0010": {
            "id": "gt0010",
            "text": "BMI ≥30 kg/m²",
            "description": "*"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "RSE Score",
            "description": "*"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "Likelihood of exacerbation in 6 months",
            "description": "*"
          },
          "gt0013": {
            "id": "gt0013",
            "text": "BMI ≥30 kg/m²"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Calculate RSE Score"
          },
          "gt0015": {
            "id": "gt0015",
            "text": "RSE Score: 1-10"
          },
          "gt0016": {
            "id": "gt0016",
            "text": "RSE Score:11-20"
          },
          "gt0017": {
            "id": "gt0017",
            "text": "RSE Score: 21-30"
          },
          "gt0018": {
            "id": "gt0018",
            "text": "RSE Score: 31-40"
          },
          "gt0019": {
            "id": "gt0019",
            "text": "RSE Score: 41-50"
          },
          "gt0020": {
            "id": "gt0020",
            "text": "RSE Score: 51-60"
          },
          "gt0021": {
            "id": "gt0021",
            "text": "RSE Score: 61-70"
          },
          "gt0022": {
            "id": "gt0022",
            "text": "RSE Score: 71-80"
          },
          "gt0023": {
            "id": "gt0023",
            "text": "RSE Score: 81-90"
          },
          "gt0024": {
            "id": "gt0024",
            "text": "RSE Score: 91-100"
          }
        }
      }
    }
  }
}